TSE:SVA Sernova (SVA) Stock Price, News & Analysis C$0.17 0.00 (0.00%) As of 03:57 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock About Sernova Stock (TSE:SVA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Sernova alerts:Sign Up Key Stats Today's RangeC$0.17▼C$0.1850-Day RangeC$0.16▼C$0.2252-Week RangeC$0.15▼C$0.40Volume108,380 shsAverage Volume151,773 shsMarket CapitalizationC$57.20 millionP/E RatioN/ADividend Yield7.86%Price TargetC$2.00Consensus RatingBuy Company OverviewSernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cells to create a bio-hybrid organ. A bio-hybrid organ refers to a medical device designed to be implanted into the human body, where it integrates with existing living tissue to replicate or enhance the function of a natural organ, essentially aiming to restore normal organ function by combining living cells with non-living materials to mimic the properties of the original organ and seamlessly interact with surrounding tissues. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on Type 1 diabetes and thyroid disorders.Read More… Receive SVA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova and its competitors with MarketBeat's FREE daily newsletter. Email Address SVA Stock News HeadlinesStocks in play: Sernova BiotherapeuticsMay 22, 2025 | ca.finance.yahoo.comSernova Biotherapeutics Inc SVAMay 16, 2025 | morningstar.comBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity is closing soon… Act now and get ready for what could be the most lucrative investment of your life.June 4, 2025 | Crypto 101 Media (Ad)Sernova Biotherapeutics Inc's (TSE:SVA) Shift From Loss To ProfitMarch 23, 2025 | finance.yahoo.comSernova Biotherapeutics Inc (SVA.TO)March 19, 2025 | finance.yahoo.comSernova Corp.: Sernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova BiotherapeuticsFebruary 11, 2025 | finanznachrichten.deJobs Reports Due for Next WeekJanuary 31, 2025 | theglobeandmail.comSernova Announces Appointment of Ross Haghighat as Chair of the Board and a Change of Name to Sernova BiotherapeuticsJanuary 30, 2025 | markets.businessinsider.comSee More Headlines SVA Stock Analysis - Frequently Asked Questions How have SVA shares performed this year? Sernova's stock was trading at C$0.23 at the beginning of the year. Since then, SVA shares have decreased by 24.4% and is now trading at C$0.17. View the best growth stocks for 2025 here. How do I buy shares of Sernova? Shares of SVA stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Sernova own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sernova investors own include ARC Resources (ARX), Meta Platforms (META), Newron Pharmaceuticals (NWPHF), Sernova (SEOVF), AMC Entertainment (AMC), Advanced Micro Devices (AMD) and CloudMD Software & Services (DOC). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:SVA CIKN/A Webwww.sinovacbio.com Phone861082890088FaxN/AEmployees1,959Year FoundedN/APrice Target and Rating Average Stock Price TargetC$2.00 High Stock Price TargetC$2.50 Low Stock Price TargetC$1.50 Potential Upside/Downside+1,076.5%Consensus RatingBuy Rating Score (0-4)3.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)C($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$35.70 million Net MarginsN/A Pretax MarginN/A Return on Equity473.85% Return on Assets-119.26% Debt Debt-to-Equity Ratio-4.40 Current Ratio0.32 Quick Ratio18.11 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.03 per share Price / Cash Flow6.15 Book ValueC($0.04) per share Price / Book-3.98Miscellaneous Outstanding Shares336,496,829Free FloatN/AMarket CapC$57.20 million OptionableNot Optionable Beta1.35 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (TSE:SVA) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump plotting new lockdown?It's listed inside the White House's own documents: Federal Register notice 90 FR 4544 to be exact. And wh...Porter & Company | SponsoredElon's silence is deafeningElon Musk tweets constantly—about DOGE, Tesla controversies, and more... But he's oddly quiet about this. ...Investors Alley | SponsoredIs Trump crashing the market on purpose?“Trump is purposefully CRASHING the market.” This is the title of a video the president recently posted to Tru...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.